comparemela.com

Latest Breaking News On - Reviva pharmaceuticals - Page 5 : comparemela.com

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Sees Significant Growth in Short Interest

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW – Get Free Report) was the recipient of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 30,700 shares, an increase of 16.3% from the December 31st total of 26,400 shares. Based on an average daily trading volume, of […]

Reviva-pharmaceuticals
News-ratings-for-reviva-pharmaceuticals-daily
Reviva-pharmaceuticals-holdings-inc
Nasdaq
Reviva-pharmaceuticals-stock-performance
Reviva-pharmaceuticals-holdings
Get-free-report
Pharmaceuticals-holdings
Reviva-pharmaceuticals-daily
Nasdaq-rvphw
Rvphw

Reviva to Present at Webull LIVE! Healthcare Webinar on January 17

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Short Interest Update

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW – Get Free Report) was the recipient of a large decline in short interest in the month of December. As of December 15th, there was short interest totalling 15,800 shares, a decline of 19.4% from the November 30th total of 19,600 shares. Based on an average trading volume of 27,200 […]

Reviva-pharmaceuticals
Reviva-pharmaceuticals-company-profile
Reviva-pharmaceuticals-holdings-inc
Reviva-pharmaceuticals-stock
Nasdaq
News-ratings-for-reviva-pharmaceuticals-daily
Reviva-pharmaceuticals-holdings
Get-free-report
Reviva-pharmaceuticals-daily
Nasdaq-rvphw
Rvphw

Reviva Pharmaceuticals' (RVPH) Buy Rating Reiterated at HC Wainwright

HC Wainwright restated their buy rating on shares of Reviva Pharmaceuticals (NASDAQ:RVPH – Free Report) in a research note published on Tuesday, Benzinga reports. They currently have a $20.00 price target on the stock. RVPH has been the topic of several other reports. Roth Mkm reissued a buy rating and issued a $12.00 price target […]

Roth-mkm
Reviva-pharmaceuticals
Renaissance-technologies
Reviva-pharmaceuticals-stock-performance
Reviva-pharmaceuticals-holdings-inc
Wells-fargo-company
News-ratings-for-reviva-pharmaceuticals-daily
Charles-schwab-investment-management-inc
Raymond-james-associates
Tower-research-capital
Hedge-funds-weigh-in-on-reviva-pharmaceuticals
Free-report

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.